Healthequity (HQY) Non-Current Deffered Revenue (2014 - 2019)

Healthequity's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $3.0 million for Q1 2019.

• On a quarterly basis, Non-Current Deffered Revenue rose 23.92% year-over-year to $3.0 million in Q1 2019; TTM through Jan 2019 was $3.0 million, a 23.92% increase from a year earlier, with the FY2019 full-year figure at $3.0 million, up 23.92% from the prior year.
• Non-Current Deffered Revenue improved to $3.0 million in Q1 2019 per HQY's latest filing, from $2.5 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $3.0 million in Q1 2019 and bottomed at $145000.0 in Q3 2015.
• The 5-year median for Non-Current Deffered Revenue is $1.3 million (2016), against an average of $1.3 million.
• Across the five-year window, Non-Current Deffered Revenue slumped 66.67% in 2015 and jumped 642.07% in 2016, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $195000.0 in 2015, then soared by 564.1% to $1.3 million in 2016, then jumped by 71.89% to $2.2 million in 2017, then grew by 10.78% to $2.5 million in 2018, then increased by 20.36% to $3.0 million in 2019.
• Per Business Quant, the three latest HQY Non-Current Deffered Revenue figures stand at $3.0 million (Q1 2019), $2.5 million (Q2 2018), and $2.4 million (Q1 2018).